自动乳腺超声联合远程读片作为乳腺癌初筛手段:一项涉及中国46家社区卫生服务中心的前瞻性研究
该前瞻性研究纳入中国18个省份46家社区卫生服务中心的5978名35-69岁无症状女性,以自动乳腺超声(ABUS)为唯一筛查手段、由技师在社区采集图像并云端传输至单一远程读片中心,由两位乳腺专科放射科医师独立判读、第三位医师解决分歧。ABUS检出24例癌症、间期癌2例,癌症检出率4.0/1000(95%CI 2.7-5.9),异常判读率11.9%(95%CI 11.1-12.7%),敏感度92.3%(95%CI 75.9-97.9%),特异度88.4%(95%CI 87.6-89.2%)。结论认为ABUS远程读片在癌症检出方面达到与乳腺X线摄影比较的基准表现,间期癌少见。
要点
- ABUS远程读片癌症检出率4.0/1000(95%CI 2.7-5.9),异常判读率11.9%(95%CI 11.1-12.7%)。
- ABUS检出癌症中95.8%(23/24)为浸润癌,23例浸润癌中位直径10.0 mm,73.9%(17/23)淋巴结阴性。
- 敏感度92.3%(95%CI 75.9-97.9%),特异度88.4%(95%CI 87.6-89.2%),活检率1.7%(95%CI 1.4-2.0%),活检PPV 24.0%(95%CI 16.7-33.2%)。
核心结论
- ABUS筛查联合远程读片在癌症检出方面达到与乳腺X线摄影比较的基准表现,间期癌少见。
- ABUS联合远程读片在乳腺X线筛查尚未建立的低资源或服务不足地区,有望改善乳腺癌筛查的可及性和早期检出。
研究设计与样本
- 前瞻性研究,2021年1月至2021年12月从中国全部六大区域的18个省份的46家社区卫生服务中心纳入35-69岁无症状女性。
- 参与者以筛查ABUS作为唯一乳腺癌筛查手段,由技师在社区卫生服务中心采集图像。
- 三维容积数据通过云端软件传输至单一远程读片中心,由两位乳腺专科放射科医师使用BI-RADS独立分批判读,远程读片中心第三位放射科医师解决分歧。
- 诊断报告返回社区中心,患者在本地医院寻求随访;参考标准结合组织病理学和24个月随访。
- 最终分析纳入5978名参与者(中位年龄46岁,IQR 40-52岁)。
诊断标准与关键数值
- 共诊断24例ABUS检出癌症和2例间期癌;癌症检出率4.0/1000女性(95%CI 2.7-5.9)。
- 异常判读率11.9%(95%CI 11.1-12.7%)。
- ABUS检出癌症中95.8%(23/24)为浸润癌;23例浸润癌中位直径10.0 mm,73.9%(17/23)淋巴结阴性。
- 敏感度92.3%(95%CI 75.9-97.9%),特异度88.4%(95%CI 87.6-89.2%)。
- 活检率1.7%(95%CI 1.4-2.0%),活检PPV 24.0%(95%CI 16.7-33.2%)。
临床应用与阅片要点
- 筛查ABUS图像由技师在社区采集后经云端传输至远程读片中心,由乳腺专科放射科医师按BI-RADS判读,可用于乳腺X线筛查未建立的低资源或服务不足地区。
- ABUS检出癌症中95.8%(23/24)为浸润癌,23例浸润癌中位直径10.0 mm且73.9%(17/23)淋巴结阴性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. China has faced barriers to implementation of a population-based mammographic screening program. Breast ultrasound provides an alternative screening modality to mammography in low-resource settings. OBJECTIVE. The purpose of this study was to evaluate the performance of automated breast ultrasound (ABUS) with remote reading as the primary screening modality for breast cancer. METHODS. This prospective study enrolled asymptomatic women 35-69 years old from 46 community health centers across 18 provinces representing all six regions of China from January 2021 to December 2021. Participants underwent screening ABUS as the sole breast cancer screening modality, with images acquired by a technologist at a community health center. The 3D volumetric data were transferred via cloud-based software to a single remote reading center, where examinations were interpreted independently in batches by two subspecialized breast radiologists using BI-RADS; a third radiologist at the remote reading center resolved discrepancies. Diagnostic reports were returned to the community centers, and patients sought follow-up care at local hospitals. The reference standard incorporated a combination of histopathology and 24-month follow-up. Outcome measures included cancer detection rate, abnormal interpretation rate (AIR), sensitivity, specificity, biopsy rate, and PPV. RESULTS. The final analysis included 5978 enrolled participants (median age, 46 years [IQR, 40-52 years]) who underwent screening ABUS at the community health centers with subsequent remote reading. A total of 24 ABUS-detected cancers and two interval cancers were diagnosed. The cancer detection rate was 4.0 per 1000 women (95% CI: 2.7-5.9), and the AIR was 11.9% (95% CI: 11.1-12.7%). A total of 95.8% (23/24) of ABUS-detected cancers were invasive. The 23 invasive cancers had a median diameter of 10.0 mm, and 73.9% (17/23) were node-negative. Sensitivity was 92.3% (95% CI: 75.9-97.9%), and specificity was 88.4% (95% CI: 87.6-89.2%). The biopsy rate was 1.7% (95% CI: 1.4-2.0%), and the PPV of biopsy was 24.0% (95% CI: 16.7-33.2%). CONCLUSION. ABUS screening with remote reading met benchmark performance for cancer detection in comparison with mammography, with infrequent interval cancers. CLINICAL IMPACT. ABUS with remote reading holds promise in enhancing access to breast cancer screening and early detection in low-resource settings or underserved regions where mammographic screening is not established. TRIAL REGISTRATION. ClinicalTrials.gov NCT04527510.
引用
- Dang X, Gao Y, Ju Y, et al. Automated Breast Ultrasound With Remote Reading for Primary Breast Cancer Screening: A Prospective Study Involving 46 Community Health Centers in China. AJR Am J Roentgenol. 2024. PMID: 39440797. doi:10.2214/AJR.24.31830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。